Fibroblast and Vascular Endothelial Growth Factor Coating of Decellularized Vascular Grafts Stimulates Undesired Giant Cells and Graft Encapsulation in a Rat Model

Artificial Organs

Volumn 35, Issue 1, 2011, Pages E1-E10

  Heidenhain, Christoph ^a   Veeravoorn, Ariyakhagorn ^b   Vachkov, Blagovest ^a   Weichert, Wilko ^a   Schmidmaier, Gerhard ^a   Wildemann, Britt ^a   Neuhaus, Peter ^a   Heise, Michael ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Encapsulation; Fibroblast growth factor; Giant cells; Vascular endothelial growth factor; Vascular grafts

Indexed keywords

ARTIFICIAL ORGANS; CELL CULTURE; COATINGS; ENDOTHELIAL CELLS; FIBROBLASTS; GRAFTS;

BIO IMPLANTS; DECELLULARIZED; ENDOTHELIAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GIANT CELLS; L-LACTIDE; RAT MODEL; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR GRAFTS; VASCULAR SURGERY;

RATS;

FIBROBLAST GROWTH FACTOR; GENIPIN; POLYLACTIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL GRAFT; CROSS LINKING; ENCAPSULATION; EOSINOPHIL; GIANT CELL; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 78651418247     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01072.x     Document Type: Article

References (42)

1. Schmitt DD, Seabrook GR, Bandyk DF, Towne JB. Graft excision and extra-anatomic revascularization: the treatment of choice for the septic aortic prosthesis. J Cardiovasc Surg (Torino) 1990;31:327-32.
2. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000;32:451-9.
3. Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg 2004;39:1009-17.
4. Allaire E, Bruneval P, Mandet C, Becquemin JP, Michel JB. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 1997;122:73-81.
5. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-56.
6. Bergmeister H, Plasenzotti R, Walter I, et al. Decellularized, xenogeneic small-diameter arteries: transition from a muscular to an elastic phenotype in vivo. J Biomed Mater Res B Appl Biomater 2008;87:95-104.
7. Zhou M, Liu Z, Wei Z, et al. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor. Artif Organs 2009;33:230-9.
8. Conklin BS, Wu H, Lin PH, Lumsden AB, Chen C. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs 2004;28:668-75.
9. Yoon JJ, Chung HJ, Lee HJ, Park TG. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 2006;79:934-42.
10. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 2001;56:216-21.
11. Cleland JL, Duenas ET, Park A, et al. Development of poly-(D, L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001;72:13-24.
12. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-801.
13. Luo Z, Asahara T, Tsurumi Y, Isner JM, Symes JF. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg 1998;27:167-73.
14. Hutter R, Carrick FE, Valdiviezo C, et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004;110:2430-5.
15. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007;28:1123-31.
16. Sung HW, Huang RN, Huang LL, Tsai CC. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed 1999;10:63-78.
17. Chang Y, Tsai CC, Liang HC, Sung HW. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002;23:2447-57.
18. Chang Y, Hsu CK, Wei HJ, et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: in vitro and in vivo studies. J Biotechnol 2005;120:207-19.Epub 2005 Aug 19.
19. Huang LL, Sung HW, Tsai CC, Huang DM. Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent. J Biomed Mater Res 1998;42:568-76.
20. Liang HC, Chang Y, Hsu CK, Lee MH, Sung HW. Effects of crosslinking degree of an acellular biological tissue on its tissue regeneration pattern. Biomaterials 2004;25:3541-52.
21. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D, L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-9.
22. Tamada JA, Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 1993;90:552-6.
23. Schmidmaier G, Wildemann B, Lübberstedt M, Haas NP, Raschke M. IGF-I and TGF-beta 1 incorporated in a poly(D, L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. J Biomed Mater Res B Appl Biomater 2003;65:157-62.
24. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D, L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 2001;58:449-55.
25. Taş C, Kozluca A, Onur MA, et al. In vivo degradation and release kinetics of chloramphenicol-loaded poly(D, L)-lactide sponges. Tissue Eng 1998;4:353-63.
26. Heise M, Schmidmaier G, Husmann I, et al. PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. Eur J Vasc Endovasc Surg 2006;32:418-24.Epub May 6, 2006.
27. Grauss RW, Hazekamp MG, van Vliet S, Gittenberger-de Groot AC, DeRuiter MC. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovasc Surg 2003;126:2003-10.
28. Hinds MT, Rowe RC, Ren Z, et al. Development of a reinforced porcine elastin composite vascular scaffold. J Biomed Mater Res A 2006;77:458-69.
29. Courtman DW, Pereira CA, Omar S, Langdon SE, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995;29:1507-16.
30. Yao C, Markowicz M, Pallua N, Noah EM, Steffens G. The effect of cross-linking of collagen matrices on their angiogenic capability. Biomaterials 2008;29:66-74.
31. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005;16:159-78.
32. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-80.
33. Hughes GC, Biswas SS, Yin B, et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. Ann Thorac Surg 2004;77:812-8.
34. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006;21:262-8.
35. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003;65:489-97.
36. Cleland JL, Duenas ET, Park A, et al. Development of poly-(D, L-lactide - coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001;72:13-24.
37. Elcin AE, Elcin YM. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng 2006;12:959-68.
38. Pieper JS, Hafmans T, van Wachem PB, et al. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 2002;62:185-94.
39. Davies N, Dobner S, Bezuidenhout D, et al. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 2008;29:3531-8.
40. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002;24:173-83.
41. Conklin BS, Wu H, Lin PH, Lumsden AB, Chen C. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs 2004;28:668-75.
42. Arkudas A, Tjiawi J, Bleiziffer O, et al. Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol Med 2007;13:480-7.